Exeter Respiratory Research & Innovation (ERI)

Exeter Respiratory Research & Innovation (ERI)

OXYPuF: Ambulatory Oxgyen Therapy for Pulmonary Fibrosis

Posted by pfc202

1 September 2022

Primary Objective:

  • To determine what is the clinical and cost effectiveness of ambulatory oxygen therapy (AOT) in patients with idiopathic pulmonary fibrosis (IPF)

Inclusion Criteria:

  • Clinically diagnosed IPF, confirmed by an ILD MDT linked to an NHS specialist commissioned IPF service
  • Breathlessness with MRC dyspnoea score ≥2

Click here to Read a Summary of this trial

More information will be available soon. Please check back soon for contact details and full PIS.

Back home Back